Combination of glucosamine and low-dose cyclosporine for atopic dermatitis treatment: A randomized, placebo-controlled, double-blind, parallel clinical trial

The novel IGF-IR/Akt–dependent anticancer activities of glucosamine

(2014) Ki-Hoon Song et al.   BMC CANCER

Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice

(2013) Chang-Hyun Kim et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Assessment of clinical signs of atopic dermatitis: A systematic review and recommendation

(2013) Jochen Schmitt et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation

(2013) Bryony Stott et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Combination of glucosamine improved therapeutic effect of low-dose cyclosporin A in patients with atopic dermatitis: A pilot study

(2013) Hyok-Bu KWON et al.   JOURNAL OF DERMATOLOGY

Glucosamine Induces Activated T Cell Apoptosis Through Reduced T Cell Receptor

(2013) N.-H. Chen et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Importance of synovitis in osteoarthritis: Evidence for the use of glycosaminoglycans against synovial inflammation

(2013) Yves Henrotin et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

IL-31 Expression by Inflammatory Cells is Preferentially Elevated in Atopic Dermatitis

(2012) GFL Hofbauer et al.   ACTA DERMATO-VENEREOLOGICA

Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis

(2012) Masutaka Furue et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis

(2012) Ulrike Raap et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference

(2011) M. E. Schram et al.   ALLERGY

Favorable clinical response by pre-prandial administration of low-dose ciclosporin to severe adult atopic dermatitis

(2011) Satoshi Nakamura et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Atopic Dermatitis Diagnostic Criteria and Outcome Measures for Clinical Trials: Still a Mess

(2011) Carsten Flohr   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Glucosamine Improved Atopic Dermatitis-like Skin Lesions in NC/Nga Mice by Inhibition of Th2 Cell Development

(2011) C.-H. Kim et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring

(2010) MHM Ezzat et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease

(2010) Luca Elli et al.   LABORATORY INVESTIGATION

Systemic Therapy of Atopic Dermatitis in Children

(2009) Giampaolo Ricci et al.   DRUGS

CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy

(2009) Yeon Sook Kwon et al.   EXPERIMENTAL DERMATOLOGY

Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition

(2008) Dae-Seok Kim et al.   CANCER LETTERS

Allergy and the skin

(2008) C. Incorvaia et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY